PLoS ONE (Jan 2012)

Tissue factor pathway inhibitor 2 is found in skin and its C-terminal region encodes for antibacterial activity.

  • Praveen Papareddy,
  • Martina Kalle,
  • Ole E Sørensen,
  • Katarina Lundqvist,
  • Matthias Mörgelin,
  • Martin Malmsten,
  • Artur Schmidtchen

DOI
https://doi.org/10.1371/journal.pone.0052772
Journal volume & issue
Vol. 7, no. 12
p. e52772

Abstract

Read online

BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI-2) is a matrix-associated serine protease inhibitor with an enigmatic function in vivo. Here, we describe that TFPI-2 is present in fibrin of wounds and also expressed in skin, where it is up-regulated upon wounding. METHODOLOGY AND PRINCIPAL FINDINGS: Neutrophil elastase cleaved TFPI-2, and a C-terminal fragment was found to bind to bacteria. Similarly, a prototypic peptide representing this C-terminal part, EDC34, bound to bacteria and bacterial lipopolysaccharide, and induced bacterial permeabilization. The peptide also induced leakage in artificial liposomes, and displayed a random coil conformation upon interactions with liposomes as well as lipopolysaccharide. EDC34 was antibacterial against both Gram-negative and Gram-positive bacteria in physiological buffer conditions. CONCLUSIONS/SIGNIFICANCE: The results demonstrate that the C-terminus of TFPI-2 encodes for antimicrobial activity, and may be released during wounding.